Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months

In This Article:

Companies that pass along profits to shareholders through dividends can be great for generating passive income. But the stock prices of income-focused companies don't always keep pace with a growth-fueled stock market rally.

However, that hasn't been the case for Kenvue (NYSE: KVUE), at least not lately, with the stock up big in just a few months.

Here's what's driving the maker of Band-Aid and other products higher, and whether you should buy the dividend stock now.

A cheerful child with a bandage on their arm.
Image source: Getty Images.

A primer on Kenvue

In August 2023, Kenvue spun off from former parent company Johnson & Johnson, creating the largest pure-play consumer health company by revenue. Kenvue operates three segments -- Self Care, Skin Health and Beauty, and Essential Health.

Self Care has 19 brands, including Tylenol and Benadryl. Neutrogena, Aveeno, and Clean & Clear are some of the 12 Skin Health and Beauty brands. Essential Health has eight brands, including Band-Aid, Listerine, and Neosporin.

Kenvue is guiding for $1.10 to $1.20 in 2024 earnings per share and 2% to 4% organic sales growth. If it achieves the midpoint of its target, Kenvue would have a price-to-earnings ratio of 20 -- so not cheap, but also not that expensive.

In July, Kenvue raised its dividend by 2.5% to $0.21 per share per quarter or $0.82 per share per year -- good for a forward yield of 3.6%. After the spin-off, Kenvue inherited J&J's status as a Dividend King, and maintained that status with the recent raise. Dividend Kings are companies that have paid and raised their dividends for at least 50 consecutive years, so Kenvue technically has a 62-year streak going. However, making minimum raises just to sustain a title is a bad look for Kenvue, and investors will assuredly be looking for more meaningful raises going forward.

All told, Kenvue is a stable, low-growth company with proven brands and a solid yield. Companies like that rarely have sharp spikes to the upside or steep sell-offs to the downside. So investors may be wondering why Kenvue is up 25.7% in the last three months, compared to a 6.4% increase in the S&P 500.

Enter the activist

Kenvue stock sold off big time this past summer, then got a jolt when it reported solid earnings and guidance. So part of the recent run-up is simply due to investors resetting expectations.

However, Kenvue stock jumped 5.5% on Oct. 21 on news that activist investor Starboard Value took on a significant stake in the company.

Starboard Value is the same company that took a stake in Starbucks, which was reported by Reuters and other outlets on Aug. 9. Then, on Aug. 13, Starbucks announced that former Chipotle CEO Brian Niccol would take over as the new CEO of Starbucks. It's unclear what role (if any) Starboard Value played in that decision. But new management is exactly the kind of change activist investors tend to look for.